Life Sciences IPOs Edge 1 Firm Ahead Of Peers In Quiet March
One firm nudged ahead of rivals based on the number of initial public offerings advised in March as it guided two life sciences deals, including one each for the issuer and...To view the full article, register now.
Already a subscriber? Click here to view full article